Stefan Cross Net Worth & Insider Trades
Stefan Cross - Director, Hedgepath Pharmaceuticals, Inc
What is Stefan Cross's Net Worth?
The current estimated net worth of Hedgepath Pharmaceuticals, Inc's Director, Stefan Cross, is estimated to be about $162.66K . Stefan Cross owns about 0 unit of Hedgepath Pharmaceuticals, Inc common stock. In the last 3 years at Hedgepath Pharmaceuticals, Inc, Stefan Cross has sold an estimated value of $162.66K worth.
What is Stefan Cross's Past Insider Trading?
Stefan Cross's largest sale order was 600,000 units , worth over $162.66K on February 12, 2018. In total, Stefan Cross has made about 3 transactions over 3 years of their time at Hedgepath Pharmaceuticals, Inc. Stefan Cross usually trades in March, August and February, with the busiest year in 2018, 2015 and 2017.
Stefan Cross
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Stefan Cross's' Mailing Address?
- Mailing address is 1240 Sugg Parkway Greenville NC 27834 NC
What are Hedgepath Pharmaceuticals, Inc's Past Insider Trades?
Hedgepath Pharmaceuticals, Inc's most recent insider trade came on August 31, 2018 by Garrison J Hasara who sold 100,000 units worth $27K . In the last 4 years, insiders at Hedgepath Pharmaceuticals, Inc have sold an estimated value of $3.56M and bought an estimated value of $2.16M worth of shares. Insider trading is most common in March, with the busiest year in 2018. The most active traders at the company are Mayne Pharma Group Ltd, Mayne Pharma International Pty Ltd, and Mayne Pharma Ventures Pty Ltd .
HedgePath Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||